Exact Mass: 702.5798087999999
Exact Mass Matches: 702.5798087999999
Found 500 metabolites which its exact mass value is equals to given mass value 702.5798087999999
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
SM(d18:1/16:0)
C39H79N2O6P (702.5675444000001)
Sphingomyelin (d18:1/16:0) or SM(d18:1/16:0) is a type of sphingolipid found in animal cell membranes, especially in the membranous myelin sheath which surrounds some nerve cell axons. It usually consists of phosphorylcholine and ceramide. SM(d18:1/16:0) consists of a sphingosine backbone and a palmitic acid chain. In humans, sphingomyelin is the only membrane phospholipid not derived from glycerol. Like all sphingolipids, SM has a ceramide core (sphingosine bonded to a fatty acid via an amide linkage). In addition, it contains one polar head group, which is either phosphocholine or phosphoethanolamine. The plasma membrane of cells is highly enriched in sphingomyelin and is considered largely to be found in the exoplasmic leaflet of the cell membrane. However, there is some evidence that there may also be a sphingomyelin pool in the inner leaflet of the membrane. Moreover, neutral sphingomyelinase-2, an enzyme that breaks down sphingomyelin into ceramide, has been found to localize exclusively to the inner leaflet further suggesting that there may be sphingomyelin present there. Sphingomyelin can accumulate in a rare hereditary disease called Niemann-Pick Disease, types A and B. Niemann-Pick disease is a genetically-inherited disease caused by a deficiency in the enzyme sphingomyelinase, which causes the accumulation of sphingomyelin in spleen, liver, lungs, bone marrow, and the brain, causing irreversible neurological damage. SMs play a role in signal transduction. Sphingomyelins are synthesized by the transfer of phosphorylcholine from phosphatidylcholine to a ceramide in a reaction catalyzed by sphingomyelin synthase. Sphingomyelin (d18:1/16:0) or SM(d18:1/16:0) is a sphingomyelin. Sphingomyelin (SM or SPH) is a type of sphingolipid found in animal cell membranes, especially in the membranous myelin sheath which surrounds some nerve cell axons. It usually consists of phosphorylcholine and ceramide. SM(18:1/16:0) consists of oleic acid attached to the C1 position and palmitic acid attached to the C2 position. In humans, sphingomyelin is the only membrane phospholipid not derived from glycerol. Like all sphingolipids, SPH has a ceramide core (sphingosine bonded to a fatty acid via an amide linkage). In addition it contains one polar head group, which is either phosphocholine or phosphoethanolamine. The plasma membrane of cells is highly enriched in sphingomyelin and is considered largely to be found in the exoplasmic leaflet of the cell membrane. However, there is some evidence that there may also be a sphingomyelin pool in the inner leaflet of the membrane. Moreover, neutral sphingomyelinase-2 - an enzyme that breaks down sphingomyelin into ceramide has been found to localise exclusively to the inner leaflet further suggesting that there may be sphingomyelin present there. Sphingomyelin can accumulate in a rare hereditary disease called Niemann-Pick Disease, types A and B. Niemann-Pick disease is a genetically-inherited disease caused by a deficiency in the enzyme Sphingomyelinase, which causes the accumulation of Sphingomyelin in spleen, liver, lungs, bone marrow, and the brain, causing irreversible neurological damage. SMs play a role in signal transduction.
SM(d18:0/16:1(9Z))
C39H79N2O6P (702.5675444000001)
Sphingomyelin (d18:0/16:1(9Z)) or SM(d18:0/16:1(9Z)) is a type of sphingolipid found in animal cell membranes, especially in the membranous myelin sheath which surrounds some nerve cell axons. It usually consists of phosphorylcholine and ceramide. In humans, sphingomyelin is the only membrane phospholipid not derived from glycerol. Like all sphingolipids, SPH has a ceramide core (sphingosine bonded to a fatty acid via an amide linkage). In addition it contains one polar head group, which is either phosphocholine or phosphoethanolamine. The plasma membrane of cells is highly enriched in sphingomyelin and is considered largely to be found in the exoplasmic leaflet of the cell membrane. However, there is some evidence that there may also be a sphingomyelin pool in the inner leaflet of the membrane. Moreover, neutral sphingomyelinase-2 - an enzyme that breaks down sphingomyelin into ceramide has been found to localise exclusively to the inner leaflet further suggesting that there may be sphingomyelin present there. Sphingomyelin can accumulate in a rare hereditary disease called Niemann-Pick Disease, types A and B. Niemann-Pick disease is a genetically-inherited disease caused by a deficiency in the enzyme Sphingomyelinase, which causes the accumulation of Sphingomyelin in spleen, liver, lungs, bone marrow, and the brain, causing irreversible neurological damage. SMs play a role in signal transduction. Sphingomyelins are synthesized by the transfer of phosphorylcholine from phosphatidylcholine to a ceramide in a reaction catalyzed by sphingomyelin synthase. Sphingomyelin (d18:0/16:1(9Z)) or SM(d18:0/16:1(9Z)) is a type of sphingolipid found in animal cell membranes, especially in the membranous myelin sheath which surrounds some nerve cell axons. It usually consists of phosphorylcholine and ceramide. In humans, sphingomyelin is the only membrane phospholipid not derived from glycerol. Like all sphingolipids, SPH has a ceramide core (sphingosine bonded to a fatty acid via an amide linkage). In addition it contains one polar head group, which is either phosphocholine or phosphoethanolamine. The plasma membrane of cells is highly enriched in sphingomyelin and is considered largely to be found in the exoplasmic leaflet of the cell membrane. However, there is some evidence that there may also be a sphingomyelin pool in the inner leaflet of the membrane. Moreover, neutral sphingomyelinase-2 - an enzyme that breaks down sphingomyelin into ceramide has been found to localise exclusively to the inner leaflet further suggesting that there may be sphingomyelin present there. Sphingomyelin can accumulate in a rare hereditary disease called Niemann-Pick Disease, types A and B. Niemann-Pick disease is a genetically-inherited disease caused by a deficiency in the enzyme Sphingomyelinase, which causes the accumulation of Sphingomyelin in spleen, liver, lungs, bone marrow, and the brain, causing irreversible neurological damage. SMs play a role in signal transduction.
DG(21:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)
DG(21:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(21:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:3(5Z,8Z,11Z)-O(14R,15S)/21:0/0:0)
DG(20:3(5Z,8Z,11Z)-O(14R,15S)/21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,11Z)-O(14R,15S)/21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(21:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))
DG(21:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/21:0)
DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(21:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)
DG(21:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(21:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:3(5Z,8Z,14Z)-O(11S,12R)/21:0/0:0)
DG(20:3(5Z,8Z,14Z)-O(11S,12R)/21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,14Z)-O(11S,12R)/21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(21:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))
DG(21:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/21:0)
DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(21:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)
DG(21:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(21:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:3(5Z,11Z,14Z)-O(8,9)/21:0/0:0)
DG(20:3(5Z,11Z,14Z)-O(8,9)/21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,11Z,14Z)-O(8,9)/21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(21:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))
DG(21:0/0:0/20:3(5Z,11Z,14Z)-O(8,9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/21:0)
DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(21:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)
DG(21:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(21:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:3(8Z,11Z,14Z)-O(5,6)/21:0/0:0)
DG(20:3(8Z,11Z,14Z)-O(5,6)/21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(8Z,11Z,14Z)-O(5,6)/21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(21:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))
DG(21:0/0:0/20:3(8Z,11Z,14Z)-O(5,6)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/21:0)
DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(21:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)
DG(21:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(21:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/21:0/0:0)
DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(21:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))
DG(21:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/21:0)
DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(21:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)
DG(21:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(21:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/21:0/0:0)
DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(21:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))
DG(21:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/21:0)
DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(21:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)
DG(21:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(21:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/21:0/0:0)
DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(21:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))
DG(21:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/21:0)
DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(21:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0)
DG(21:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(21:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/21:0/0:0)
DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(21:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))
DG(21:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/21:0)
DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(21:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0)
DG(21:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(21:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/21:0/0:0)
DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(21:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17))
DG(21:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/21:0)
DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(21:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0)
DG(21:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(21:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/21:0/0:0)
DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(21:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))
DG(21:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/21:0)
DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(21:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0)
DG(21:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(21:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/21:0/0:0)
DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(21:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S))
DG(21:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/21:0)
DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(21:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0)
DG(21:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(21:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/21:0/0:0)
DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(21:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S))
DG(21:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/21:0)
DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(21:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0)
DG(21:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(21:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/21:0/0:0)
DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(21:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R))
DG(21:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/21:0)
DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(21:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0)
DG(21:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(21:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,7E,11Z,14Z)-OH(9)/21:0/0:0)
DG(20:4(5Z,7E,11Z,14Z)-OH(9)/21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,7E,11Z,14Z)-OH(9)/21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(21:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9))
DG(21:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/21:0)
DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(a-21:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)
DG(a-21:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-21:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:3(5Z,8Z,11Z)-O(14R,15S)/a-21:0/0:0)
DG(20:3(5Z,8Z,11Z)-O(14R,15S)/a-21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,11Z)-O(14R,15S)/a-21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(a-21:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))
DG(a-21:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/a-21:0)
DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/a-21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(a-21:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)
DG(a-21:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-21:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:3(5Z,8Z,14Z)-O(11S,12R)/a-21:0/0:0)
DG(20:3(5Z,8Z,14Z)-O(11S,12R)/a-21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,14Z)-O(11S,12R)/a-21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(a-21:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))
DG(a-21:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/a-21:0)
DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/a-21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(a-21:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)
DG(a-21:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-21:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:3(5Z,11Z,14Z)-O(8,9)/a-21:0/0:0)
DG(20:3(5Z,11Z,14Z)-O(8,9)/a-21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,11Z,14Z)-O(8,9)/a-21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(a-21:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))
DG(a-21:0/0:0/20:3(5Z,11Z,14Z)-O(8,9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/a-21:0)
DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/a-21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(a-21:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)
DG(a-21:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-21:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:3(8Z,11Z,14Z)-O(5,6)/a-21:0/0:0)
DG(20:3(8Z,11Z,14Z)-O(5,6)/a-21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(8Z,11Z,14Z)-O(5,6)/a-21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(a-21:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))
DG(a-21:0/0:0/20:3(8Z,11Z,14Z)-O(5,6)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/a-21:0)
DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/a-21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(a-21:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)
DG(a-21:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-21:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/a-21:0/0:0)
DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/a-21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/a-21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(a-21:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))
DG(a-21:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/a-21:0)
DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/a-21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(a-21:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)
DG(a-21:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-21:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/a-21:0/0:0)
DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/a-21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/a-21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(a-21:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))
DG(a-21:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/a-21:0)
DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/a-21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(a-21:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)
DG(a-21:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-21:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/a-21:0/0:0)
DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/a-21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/a-21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(a-21:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))
DG(a-21:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/a-21:0)
DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/a-21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(a-21:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0)
DG(a-21:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-21:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/a-21:0/0:0)
DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/a-21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/a-21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(a-21:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))
DG(a-21:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/a-21:0)
DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/a-21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(a-21:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0)
DG(a-21:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-21:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/a-21:0/0:0)
DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/a-21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/a-21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(a-21:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17))
DG(a-21:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/a-21:0)
DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/a-21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(a-21:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0)
DG(a-21:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-21:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/a-21:0/0:0)
DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/a-21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/a-21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(a-21:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))
DG(a-21:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/a-21:0)
DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/a-21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(a-21:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0)
DG(a-21:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-21:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/a-21:0/0:0)
DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/a-21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/a-21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(a-21:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S))
DG(a-21:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/a-21:0)
DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/a-21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(a-21:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0)
DG(a-21:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-21:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/a-21:0/0:0)
DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/a-21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/a-21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(a-21:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S))
DG(a-21:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/a-21:0)
DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/a-21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(a-21:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0)
DG(a-21:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-21:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/a-21:0/0:0)
DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/a-21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/a-21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(a-21:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R))
DG(a-21:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/a-21:0)
DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/a-21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(a-21:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0)
DG(a-21:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-21:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,7E,11Z,14Z)-OH(9)/a-21:0/0:0)
DG(20:4(5Z,7E,11Z,14Z)-OH(9)/a-21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,7E,11Z,14Z)-OH(9)/a-21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(a-21:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9))
DG(a-21:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/a-21:0)
DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/a-21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-21:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)
DG(i-21:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-21:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:3(5Z,8Z,11Z)-O(14R,15S)/i-21:0/0:0)
DG(20:3(5Z,8Z,11Z)-O(14R,15S)/i-21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,11Z)-O(14R,15S)/i-21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-21:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))
DG(i-21:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/i-21:0)
DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/i-21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-21:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)
DG(i-21:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-21:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:3(5Z,8Z,14Z)-O(11S,12R)/i-21:0/0:0)
DG(20:3(5Z,8Z,14Z)-O(11S,12R)/i-21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,14Z)-O(11S,12R)/i-21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-21:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))
DG(i-21:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/i-21:0)
DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/i-21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-21:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)
DG(i-21:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-21:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:3(5Z,11Z,14Z)-O(8,9)/i-21:0/0:0)
DG(20:3(5Z,11Z,14Z)-O(8,9)/i-21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,11Z,14Z)-O(8,9)/i-21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-21:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))
DG(i-21:0/0:0/20:3(5Z,11Z,14Z)-O(8,9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/i-21:0)
DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/i-21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-21:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)
DG(i-21:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-21:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:3(8Z,11Z,14Z)-O(5,6)/i-21:0/0:0)
DG(20:3(8Z,11Z,14Z)-O(5,6)/i-21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(8Z,11Z,14Z)-O(5,6)/i-21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-21:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))
DG(i-21:0/0:0/20:3(8Z,11Z,14Z)-O(5,6)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/i-21:0)
DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/i-21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-21:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)
DG(i-21:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-21:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/i-21:0/0:0)
DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/i-21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/i-21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-21:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))
DG(i-21:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/i-21:0)
DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/i-21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-21:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)
DG(i-21:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-21:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/i-21:0/0:0)
DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/i-21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/i-21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-21:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))
DG(i-21:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/i-21:0)
DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/i-21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-21:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)
DG(i-21:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-21:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/i-21:0/0:0)
DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/i-21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/i-21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-21:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))
DG(i-21:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/i-21:0)
DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/i-21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-21:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0)
DG(i-21:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-21:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/i-21:0/0:0)
DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/i-21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/i-21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-21:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))
DG(i-21:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/i-21:0)
DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/i-21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-21:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0)
DG(i-21:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-21:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/i-21:0/0:0)
DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/i-21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/i-21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-21:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17))
DG(i-21:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/i-21:0)
DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/i-21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-21:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0)
DG(i-21:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-21:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/i-21:0/0:0)
DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/i-21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/i-21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-21:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))
DG(i-21:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/i-21:0)
DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/i-21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-21:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0)
DG(i-21:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-21:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/i-21:0/0:0)
DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/i-21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/i-21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-21:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S))
DG(i-21:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/i-21:0)
DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/i-21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-21:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0)
DG(i-21:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-21:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/i-21:0/0:0)
DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/i-21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/i-21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-21:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S))
DG(i-21:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/i-21:0)
DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/i-21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-21:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0)
DG(i-21:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-21:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/i-21:0/0:0)
DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/i-21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/i-21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-21:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R))
DG(i-21:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/i-21:0)
DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/i-21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-21:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0)
DG(i-21:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-21:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,7E,11Z,14Z)-OH(9)/i-21:0/0:0)
DG(20:4(5Z,7E,11Z,14Z)-OH(9)/i-21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,7E,11Z,14Z)-OH(9)/i-21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-21:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9))
DG(i-21:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/i-21:0)
DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/i-21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
SM d34:1
C39H79N2O6P (702.5675444000001)
Found in mouse muscle; TwoDicalId=103; MgfFile=160824_Muscle_AA_Neg_16; MgfId=717 Found in mouse kidney; TwoDicalId=22; MgfFile=160827_Kidney_normal_Neg_05; MgfId=1088
(2-{[2-hexadecanamido-3-hydroxyoctadec-4-en-1-yl phosphono]oxy}ethyl)trimethylazanium
C39H79N2O6P (702.5675444000001)
PE-Cer(d14:1/23:0)
C39H79N2O6P (702.5675444000001)
PE-Cer(d15:1/22:0)
C39H79N2O6P (702.5675444000001)
PE-Cer(d16:1/21:0)
C39H79N2O6P (702.5675444000001)
SM 34:1;O2
C39H79N2O6P (702.5675444000001)
CerPE 37:1;O2
C39H79N2O6P (702.5675444000001)
(2S,3R,4E)-2-(heptadecanoylamino)-3-hydroxy-15-methylhexadec-4-en-1-yl 2-(trimethylazaniumyl)ethyl phosphate
C39H79N2O6P (702.5675444000001)
[(E)-3-hydroxy-2-(pentanoylamino)nonacos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C39H79N2O6P (702.5675444000001)
[(E)-2-(hexanoylamino)-3-hydroxyoctacos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C39H79N2O6P (702.5675444000001)
[(E)-2-(heptanoylamino)-3-hydroxyheptacos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C39H79N2O6P (702.5675444000001)
[(E)-3-hydroxy-2-(propanoylamino)hentriacont-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C39H79N2O6P (702.5675444000001)
[(E)-2-(butanoylamino)-3-hydroxytriacont-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C39H79N2O6P (702.5675444000001)
[(E)-3-hydroxy-2-(pentacosanoylamino)non-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C39H79N2O6P (702.5675444000001)
[(E)-2-acetamido-3-hydroxydotriacont-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C39H79N2O6P (702.5675444000001)
[(E)-3-hydroxy-2-(nonanoylamino)pentacos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C39H79N2O6P (702.5675444000001)
[(E)-2-(hexacosanoylamino)-3-hydroxyoct-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C39H79N2O6P (702.5675444000001)
[(E)-3-hydroxy-2-(octanoylamino)hexacos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C39H79N2O6P (702.5675444000001)
[(E)-2-(decanoylamino)-3-hydroxytetracos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C39H79N2O6P (702.5675444000001)
[(E)-2-(docosanoylamino)-3-hydroxydodec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C39H79N2O6P (702.5675444000001)
[2-[[(Z)-henicos-11-enoyl]amino]-3-hydroxytridecyl] 2-(trimethylazaniumyl)ethyl phosphate
C39H79N2O6P (702.5675444000001)
[2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxyoctadecyl] 2-(trimethylazaniumyl)ethyl phosphate
C39H79N2O6P (702.5675444000001)
[3-hydroxy-2-[[(Z)-tetracos-13-enoyl]amino]decyl] 2-(trimethylazaniumyl)ethyl phosphate
C39H79N2O6P (702.5675444000001)
[3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]henicosyl] 2-(trimethylazaniumyl)ethyl phosphate
C39H79N2O6P (702.5675444000001)
[(E)-3-hydroxy-2-(tricosanoylamino)undec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C39H79N2O6P (702.5675444000001)
[2-[[(Z)-docos-13-enoyl]amino]-3-hydroxydodecyl] 2-(trimethylazaniumyl)ethyl phosphate
C39H79N2O6P (702.5675444000001)
[(E)-2-(henicosanoylamino)-3-hydroxytridec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C39H79N2O6P (702.5675444000001)
[2-[[(Z)-heptadec-9-enoyl]amino]-3-hydroxyheptadecyl] 2-(trimethylazaniumyl)ethyl phosphate
C39H79N2O6P (702.5675444000001)
[3-hydroxy-2-[[(Z)-octadec-9-enoyl]amino]hexadecyl] 2-(trimethylazaniumyl)ethyl phosphate
C39H79N2O6P (702.5675444000001)
[(E)-3-hydroxy-2-(tetracosanoylamino)dec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C39H79N2O6P (702.5675444000001)
[(E)-3-hydroxy-2-(undecanoylamino)tricos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C39H79N2O6P (702.5675444000001)
(2-nonanoyloxy-3-octanoyloxypropyl) (10Z,13Z,16Z)-tetracosa-10,13,16-trienoate
[3-nonanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropyl] (9Z,12Z)-nonadeca-9,12-dienoate
(2-dodecanoyloxy-3-nonanoyloxypropyl) (11Z,14Z,17Z)-icosa-11,14,17-trienoate
[3-nonanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] (9Z,12Z)-octadeca-9,12-dienoate
[2-[(Z)-hexadec-9-enoyl]oxy-3-octanoyloxypropyl] (9Z,12Z)-heptadeca-9,12-dienoate
(2-decanoyloxy-3-nonanoyloxypropyl) (10Z,13Z,16Z)-docosa-10,13,16-trienoate
[2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-octanoyloxypropyl] heptadecanoate
[3-octanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] (9Z,12Z)-nonadeca-9,12-dienoate
(3-octanoyloxy-2-tridecanoyloxypropyl) (11Z,14Z,17Z)-icosa-11,14,17-trienoate
[1-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-nonanoyloxypropan-2-yl] hexadecanoate
[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-octanoyloxypropyl] (Z)-heptadec-9-enoate
[3-nonanoyloxy-2-[(Z)-pentadec-9-enoyl]oxypropyl] (9Z,12Z)-heptadeca-9,12-dienoate
[3-octanoyloxy-2-[(Z)-pentadec-9-enoyl]oxypropyl] (9Z,12Z)-octadeca-9,12-dienoate
(3-nonanoyloxy-2-tetradecanoyloxypropyl) (9Z,12Z,15Z)-octadeca-9,12,15-trienoate
[3-octanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropyl] (11Z,14Z)-icosa-11,14-dienoate
(3-octanoyloxy-2-undecanoyloxypropyl) (10Z,13Z,16Z)-docosa-10,13,16-trienoate
(3-octanoyloxy-2-pentadecanoyloxypropyl) (9Z,12Z,15Z)-octadeca-9,12,15-trienoate
[1-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-nonanoyloxypropan-2-yl] (Z)-hexadec-9-enoate
[3-decanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropyl] (9Z,12Z)-octadeca-9,12-dienoate
(3-decanoyloxy-2-pentadecanoyloxypropyl) (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate
[3-decanoyloxy-2-[(Z)-pentadec-9-enoyl]oxypropyl] (9Z,12Z)-hexadeca-9,12-dienoate
[2-[(Z)-tetradec-9-enoyl]oxy-3-undecanoyloxypropyl] (9Z,12Z)-hexadeca-9,12-dienoate
(2-dodecanoyloxy-3-undecanoyloxypropyl) (9Z,12Z,15Z)-octadeca-9,12,15-trienoate
[2-[(Z)-tetradec-9-enoyl]oxy-3-[(Z)-tridec-9-enoyl]oxypropyl] (Z)-tetradec-9-enoate
(2-tetradecanoyloxy-3-undecanoyloxypropyl) (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate
(3-decanoyloxy-2-tridecanoyloxypropyl) (9Z,12Z,15Z)-octadeca-9,12,15-trienoate
2,3-bis[[(Z)-tridec-9-enoyl]oxy]propyl (Z)-pentadec-9-enoate
[3-dodecanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropyl] (9Z,12Z)-hexadeca-9,12-dienoate
[2-[(Z)-tridec-9-enoyl]oxy-3-undecanoyloxypropyl] (9Z,12Z)-heptadeca-9,12-dienoate
(3-dodecanoyloxy-2-tridecanoyloxypropyl) (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate
[3-decanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] (9Z,12Z)-heptadeca-9,12-dienoate
(3-decanoyloxy-2-undecanoyloxypropyl) (11Z,14Z,17Z)-icosa-11,14,17-trienoate
3,5-Dioxa-8-aza-4-phosphatetracosan-1-aminium, 4-hydroxy-7-[(1S,2E)-1-hydroxy-2-hexadecenyl]-N,N,N-trimethyl-9-oxo-, inner salt, 4-oxide, (7R)-
C39H79N2O6P (702.5675444000001)
[2-[[(Z)-hexacos-15-enoyl]amino]-3-hydroxyoctyl] 2-(trimethylazaniumyl)ethyl phosphate
C39H79N2O6P (702.5675444000001)
[(E)-3-hydroxy-2-(tetradecanoylamino)icos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C39H79N2O6P (702.5675444000001)
[3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]icosyl] 2-(trimethylazaniumyl)ethyl phosphate
C39H79N2O6P (702.5675444000001)
[3-[(3Z,6Z,9Z)-dodeca-3,6,9-trienoyl]oxy-2-tridecanoyloxypropyl] hexadecanoate
[3-tridecanoyloxy-2-[(Z)-tridec-8-enoyl]oxypropyl] (9Z,12Z)-pentadeca-9,12-dienoate
[3-dodecanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] (9Z,12Z)-pentadeca-9,12-dienoate
[3-dodecanoyloxy-2-[(5Z,8Z,11Z)-tetradeca-5,8,11-trienoyl]oxypropyl] pentadecanoate
[3-dodecanoyloxy-2-[(Z)-tridec-8-enoyl]oxypropyl] (4Z,7Z)-hexadeca-4,7-dienoate
(3-dodecanoyloxy-2-tridecanoyloxypropyl) (9Z,11Z,13Z)-hexadeca-9,11,13-trienoate
2,3-di(dodecanoyloxy)propyl (8Z,11Z,14Z)-heptadeca-8,11,14-trienoate
[1-[(7Z,9Z)-tetradeca-7,9-dienoyl]oxy-3-[(Z)-tridec-8-enoyl]oxypropan-2-yl] tetradecanoate
[3-dodecanoyloxy-2-[(3Z,6Z,9Z)-dodeca-3,6,9-trienoyl]oxypropyl] heptadecanoate
[2-[(6Z,9Z)-dodeca-6,9-dienoyl]oxy-3-dodecanoyloxypropyl] (Z)-heptadec-7-enoate
[3-[(Z)-dodec-5-enoyl]oxy-2-tetradecanoyloxypropyl] (9Z,12Z)-pentadeca-9,12-dienoate
[3-[(6Z,9Z)-dodeca-6,9-dienoyl]oxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] pentadecanoate
[3-[(Z)-dodec-5-enoyl]oxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] (Z)-pentadec-9-enoate
[3-[(6Z,9Z)-dodeca-6,9-dienoyl]oxy-2-tridecanoyloxypropyl] (Z)-hexadec-7-enoate
(3-dodecanoyloxy-2-tetradecanoyloxypropyl) (6Z,9Z,12Z)-pentadeca-6,9,12-trienoate
[1-[(7Z,9Z)-tetradeca-7,9-dienoyl]oxy-3-tridecanoyloxypropan-2-yl] (Z)-tetradec-9-enoate
[3-[(Z)-dodec-5-enoyl]oxy-2-tridecanoyloxypropyl] (4Z,7Z)-hexadeca-4,7-dienoate
[3-[(3Z,6Z,9Z)-dodeca-3,6,9-trienoyl]oxy-2-tetradecanoyloxypropyl] pentadecanoate
2,3-di(tridecanoyloxy)propyl (6Z,9Z,12Z)-pentadeca-6,9,12-trienoate
[3-[(6Z,9Z)-dodeca-6,9-dienoyl]oxy-2-tetradecanoyloxypropyl] (Z)-pentadec-9-enoate
2,3-bis[[(Z)-tridec-8-enoyl]oxy]propyl (Z)-pentadec-9-enoate
2,3-bis[[(Z)-dodec-5-enoyl]oxy]propyl (Z)-heptadec-7-enoate
[3-[(Z)-dodec-5-enoyl]oxy-2-[(7Z,9Z)-tetradeca-7,9-dienoyl]oxypropyl] pentadecanoate
[3-[(Z)-dodec-5-enoyl]oxy-2-[(Z)-tridec-8-enoyl]oxypropyl] (Z)-hexadec-7-enoate
[2-[(6Z,9Z)-dodeca-6,9-dienoyl]oxy-3-[(Z)-dodec-5-enoyl]oxypropyl] heptadecanoate
[3-[(6Z,9Z)-dodeca-6,9-dienoyl]oxy-2-[(Z)-tridec-8-enoyl]oxypropyl] hexadecanoate
[2-[(Z)-tetradec-9-enoyl]oxy-3-[(Z)-tridec-8-enoyl]oxypropyl] (Z)-tetradec-9-enoate
[3-dodecanoyloxy-2-[(7Z,9Z)-tetradeca-7,9-dienoyl]oxypropyl] (Z)-pentadec-9-enoate
[1-[(5Z,8Z,11Z)-tetradeca-5,8,11-trienoyl]oxy-3-tridecanoyloxypropan-2-yl] tetradecanoate
[3-dodecanoyloxy-2-[(Z)-dodec-5-enoyl]oxypropyl] (11Z,14Z)-heptadeca-11,14-dienoate
TG(41:3)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved